| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 75.14× | 75.14× | 80.27× | 73.97× | 78.02× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2.57× | 2.89× | 3.07× | 2.61× | 2.21× | ||
| 1.09× | 1.09× | 1.18× | 1.25× | 1.23× | ||
| 1.14× | 1.14× | 1.17× | 1.14× | 1.11× | ||
| 0.75× | 0.75× | 0.78× | 0.78× | 0.76× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 78.02 | 73.97 | 80.27 | 75.14 | 75.14 | |
| Working Capital Turnover | 2.21 | 2.61 | 3.07 | 2.89 | 2.57 | |
| Asset Turnover | 1.23 | 1.25 | 1.18 | 1.09 | 1.09 | |
| Cash Conversion (CFO/Net Income) | 1.11 | 1.14 | 1.17 | 1.14 | 1.14 | |
| CFO/EBITDA | 0.76 | 0.78 | 0.78 | 0.75 | 0.75 |